US Patent Issued to Sloan-Kettering Institute for Cancer Research on Nov. 18 for "Treatment of neurodegenerative diseases through inhibiton of Hsp90" (American, Portuguese Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,288, issued on Nov. 18, was assigned to Sloan-Kettering Institute for Cancer Research (New York).

"Treatment of neurodegenerative diseases through inhibiton of Hsp90" was invented by Gabriela Chiosis (New York), Huazhong He (New York) and Danuta Zatorska (Ericeira, Portugal).

According to the abstract* released by the U.S. Patent & Trademark Office: "Treatment of neurodegenerative diseases is achieved using small molecule purine scaffold compounds that inhibit Hsp90 and that possess the ability to cross the blood-brain barrier or are otherwise delivered to the brain."

The patent was filed on May 26, 2023, under Application No. 18/202,704.

*For further information, including ima...